Reinforcement learning and Bayesian data assimilation for model-informed precision dosing in oncology

• URL: http://arxiv.org/abs/2006.01061v1
• Date: Mon, 1 Jun 2020 16:38:27 GMT
• Title: Reinforcement learning and Bayesian data assimilation for model-informed precision dosing in oncology
• Authors: Corinna Maier, Niklas Hartung, Charlotte Kloft, Wilhelm Huisinga, and Jana de Wiljes
• Abstract summary: Current strategies comprise model-informed dosing tables or are based on maximum a-posteriori estimates. We propose three novel approaches for MIPD employing Bayesian data assimilation and/or reinforcement learning to control neutropenia. These approaches have the potential to substantially reduce the incidence of life-threatening grade 4 and subtherapeutic grade 0 neutropenia.
• Score: 0.0
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Model-informed precision dosing (MIPD) using therapeutic drug/biomarker monitoring offers the opportunity to significantly improve the efficacy and safety of drug therapies. Current strategies comprise model-informed dosing tables or are based on maximum a-posteriori estimates. These approaches, however, lack a quantification of uncertainty and/or consider only part of the available patient-specific information. We propose three novel approaches for MIPD employing Bayesian data assimilation (DA) and/or reinforcement learning (RL) to control neutropenia, the major dose-limiting side effect in anticancer chemotherapy. These approaches have the potential to substantially reduce the incidence of life-threatening grade 4 and subtherapeutic grade 0 neutropenia compared to existing approaches. We further show that RL allows to gain further insights by identifying patient factors that drive dose decisions. Due to its flexibility, the proposed combined DA-RL approach can easily be extended to integrate multiple endpoints or patient-reported outcomes, thereby promising important benefits for future personalized therapies.

Related papers

• Causal machine learning for predicting treatment outcomes [75.13093479526151]
  Causal machine learning (ML) offers flexible, data-driven methods for predicting treatment outcomes. Key benefit of causal ML is that it allows for estimating individualized treatment effects.
  arXiv  Detail & Related papers  (2024-10-11T12:39:08Z)
• Development and Validation of Heparin Dosing Policies Using an Offline Reinforcement Learning Algorithm [0.7519918949973486]
  This study proposes a reinforcement learning-based personalized optimal heparin dosing policy. A batch-constrained policy was implemented to minimize out-of-distribution errors in an offline RL environment. This research enhances heparin administration practices and establishes a precedent for the development of sophisticated decision-support tools in medicine.
  arXiv  Detail & Related papers  (2024-09-24T05:20:38Z)
• OMG-RL:Offline Model-based Guided Reward Learning for Heparin Treatment [0.4998632546280975]
  This study focuses on developing a reward function that reflects the clinician's intentions. We learn a parameterized reward function that includes the expert's intentions from limited data. This approach can be broadly utilized not only for the heparin dosing problem but also for RL-based medication dosing tasks in general.
  arXiv  Detail & Related papers  (2024-09-20T07:51:37Z)
• CIDGMed: Causal Inference-Driven Medication Recommendation with Enhanced Dual-Granularity Learning [10.60553153370577]
  Medication recommendation aims to integrate patients' long-term health records to provide accurate and safe medication combinations. Existing methods often fail to deeply explore the true causal relationships between diseases/procedures and medications. We propose the Causal Inference-driven Dual-Granularity Medication Recommendation method (CIDGMed)
  arXiv  Detail & Related papers  (2024-03-01T08:50:27Z)
• Large Language Models for Healthcare Data Augmentation: An Example on Patient-Trial Matching [49.78442796596806]
  We propose an innovative privacy-aware data augmentation approach for patient-trial matching (LLM-PTM) Our experiments demonstrate a 7.32% average improvement in performance using the proposed LLM-PTM method, and the generalizability to new data is improved by 12.12%.
  arXiv  Detail & Related papers  (2023-03-24T03:14:00Z)
• Benchmarking Heterogeneous Treatment Effect Models through the Lens of Interpretability [82.29775890542967]
  Estimating personalized effects of treatments is a complex, yet pervasive problem. Recent developments in the machine learning literature on heterogeneous treatment effect estimation gave rise to many sophisticated, but opaque, tools. We use post-hoc feature importance methods to identify features that influence the model's predictions.
  arXiv  Detail & Related papers  (2022-06-16T17:59:05Z)
• Learning-Based sensitivity analysis and feedback design for drug delivery of mixed therapy of cancer in the presence of high model uncertainties [0.0]
  It is shown that dash-boards can be built in the 2D-space of the most influent state components that summarize the outcomes' probabilities and the associated drug usage as iso-values curves in the reduced state space. It is shown that dash-boards can be built in the 2D-space of the most influent state components that summarize the outcomes' probabilities and the associated drug usage as iso-values curves in the reduced state space.
  arXiv  Detail & Related papers  (2022-05-16T07:08:50Z)
• Clinical Outcome Prediction from Admission Notes using Self-Supervised Knowledge Integration [55.88616573143478]
  Outcome prediction from clinical text can prevent doctors from overlooking possible risks. Diagnoses at discharge, procedures performed, in-hospital mortality and length-of-stay prediction are four common outcome prediction targets. We propose clinical outcome pre-training to integrate knowledge about patient outcomes from multiple public sources.
  arXiv  Detail & Related papers  (2021-02-08T10:26:44Z)
• A standardized framework for risk-based assessment of treatment effect heterogeneity in observational healthcare databases [60.07352590494571]
  The aim of this study was to extend this approach to the observational setting using a standardized scalable framework. We demonstrate our framework by evaluating the effect of angiotensin-converting enzyme (ACE) inhibitors versus beta blockers on three efficacy and six safety outcomes.
  arXiv  Detail & Related papers  (2020-10-13T14:48:31Z)
• Kernel Assisted Learning for Personalized Dose Finding [20.52632915107782]
  An individualized dose rule recommends a dose level within a continuous safe dose range based on patient level information. In this article, we propose a kernel assisted learning method for estimating the optimal individualized dose rule.
  arXiv  Detail & Related papers  (2020-07-19T23:03:26Z)
• Interpretable Off-Policy Evaluation in Reinforcement Learning by Highlighting Influential Transitions [48.91284724066349]
  Off-policy evaluation in reinforcement learning offers the chance of using observational data to improve future outcomes in domains such as healthcare and education. Traditional measures such as confidence intervals may be insufficient due to noise, limited data and confounding. We develop a method that could serve as a hybrid human-AI system, to enable human experts to analyze the validity of policy evaluation estimates.
  arXiv  Detail & Related papers  (2020-02-10T00:26:43Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.